Compounds > niacinamide

niacinamide and deoxyglucose

niacinamide has been researched along with deoxyglucose in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19902 (16.67)18.7374
1990's2 (16.67)18.2507
2000's2 (16.67)29.6817
2010's5 (41.67)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Doi, K1
Kawada, J; Nishida, M; Sofue, M; Yoshimura, Y1
Grunfeld, C; Shigenaga, JK1
Holm, BA; Hudak, BB; Maloney, C; Sokolowski, J; Tufariello, J1
Bustamante, F; Donnet, C; Fischbarg, J; Ortega, M; Reyes, AM; Rivas, CI; Rossi, JP; Vera, JC1
Cárcamo, JG; Castro, M; Concha, II; Ojeda, L; Ojeda, P; Ortega, M; Pérez, A; Rauch, MC; Reyes, AM; Rivas, CI; Sánchez, C; Valenzuela, X; Vera, JC1
Barba, M; Bernardini, C; Castellini, L; Gasbarrini, A; Maulucci, G; Pani, G; Piscaglia, AC; Pontoglio, A; Puglisi, MA; Samengo, D; Scatena, R; Spelbrink, JN; Tesori, V1
Cheng, SP; Chuang, JH; Lin, LL; Shieh, DB; Wang, PW; Wang, SY; Wei, YH1
Garcia-Manero, G; Hu, Y; Huang, A; Huang, P; Ju, HQ; Liu, D; Liu, K; Wen, S; Zhan, G1
Ghoshal, K; Jacob, ST; Motiwala, T; Reyes, R; Wani, NA1
Garcia-Manero, G; Hu, Y; Huang, A; Huang, P; Ju, HQ; Li, J; Li, Y; Lu, WH; Sun, Y; Wen, S; Xu, RH; Yang, J; Zhan, G1
Becker, M; Bedke, J; Büttner, FA; Fend, F; Haag, M; Hennenlotter, J; Hofmann, U; Klumpp, V; Leuthold, P; Menig, LS; Rausch, S; Reustle, A; Schaeffeler, E; Scharpf, M; Schmees, C; Schwab, M; Stenzl, A; Stühler, V; Winter, S1

Other Studies

12 other study(ies) available for niacinamide and deoxyglucose

ArticleYear
[Studies on the mechanism of the diabetogenic activity of streptozotocin and on the ability of compounds to block the diabetogenic activity of streptozotocin (author's transl)].
    Nihon Naibunpi Gakkai zasshi, 1975, Mar-20, Volume: 51, Issue:3

    Topics: Adenoma, Islet Cell; Amides; Animals; Blood Glucose; Cats; Cystine; Deoxyglucose; Diabetes Mellitus; Dimethylnitrosamine; Fatty Acids, Nonesterified; Glutathione; Guinea Pigs; Insulin; Islets of Langerhans; Male; Mannoheptulose; Mice; NAD; Niacinamide; Nicotinic Acids; Pancreatic Neoplasms; Picolinic Acids; Pyrazinamide; Rabbits; Rats; Streptozocin; Tolbutamide; Uric Acid

1975
Uptake of nicotinamide by rat pancreatic beta cells with regard to streptozotocin action.
    The Journal of endocrinology, 1991, Volume: 131, Issue:1

    Topics: Adenosine Triphosphate; Animals; Carbon Radioisotopes; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cells, Cultured; Deoxyglucose; Depression, Chemical; Dose-Response Relationship, Drug; Insulin; Intracellular Fluid; Islets of Langerhans; Niacinamide; Oligomycins; Rats; Rats, Inbred Strains; Streptozocin; Tritium

1991
Nicotinamide and other inhibitors of ADP-ribosylation block deoxyglucose uptake in cultured cells.
    Biochemical and biophysical research communications, 1984, Sep-17, Volume: 123, Issue:2

    Topics: Adenosine Diphosphate Ribose; Adipose Tissue; Animals; Antibodies; Bone and Bones; Cell Line; Deoxy Sugars; Deoxyglucose; Insulin; Kidney; Mice; Niacin; Niacinamide; Nucleoside Diphosphate Sugars; Pyridoxine; Receptor, Insulin

1984
Inhibition of poly(ADP-ribose) polymerase preserves surfactant synthesis after hydrogen peroxide exposure.
    The American journal of physiology, 1995, Volume: 269, Issue:1 Pt 1

    Topics: Adenosine Triphosphate; Animals; Benzamides; Deoxyglucose; Free Radical Scavengers; Hydrogen Peroxide; NAD; Niacinamide; Phosphatidylcholines; Poly(ADP-ribose) Polymerase Inhibitors; Pulmonary Alveoli; Pulmonary Surfactants; Rabbits

1995
Nicotinamide is not a substrate of the facilitative hexose transporter GLUT1.
    Biochemistry, 2002, Jun-25, Volume: 41, Issue:25

    Topics: 3-O-Methylglucose; Animals; CHO Cells; Cricetinae; Cytochalasin B; Deoxyglucose; Erythrocyte Membrane; Erythrocytes; Flavonoids; Genistein; Glucose Transporter Type 1; Humans; Monosaccharide Transport Proteins; Niacinamide; Protein Binding; Transfection; Transport Vesicles

2002
Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.
    American journal of physiology. Cell physiology, 2009, Volume: 297, Issue:1

    Topics: 3-O-Methylglucose; Animals; Antigens, CD; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Cytochalasin B; Deoxyglucose; Dose-Response Relationship, Drug; Erythrocytes; Glucose; Glucose Transporter Type 1; Gossypol; HL-60 Cells; Humans; Kinetics; Models, Biological; Niacinamide; Receptor, Insulin; Spectrometry, Fluorescence; Transfection

2009
The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing.
    Scientific reports, 2015, Mar-17, Volume: 5

    Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Autophagy; Cell Line, Tumor; Cell Respiration; Cell Survival; Deoxyglucose; Energy Metabolism; Glycolysis; Mitochondria; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Rats; Reactive Oxygen Species; Signal Transduction; Sorafenib; TOR Serine-Threonine Kinases

2015
2-Deoxy-d-Glucose Can Complement Doxorubicin and Sorafenib to Suppress the Growth of Papillary Thyroid Carcinoma Cells.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Adenosine Triphosphate; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyglucose; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Synergism; Gene Expression; Glycolysis; Humans; Lactic Acid; Mutation; Niacinamide; Oxygen Consumption; Phenylurea Compounds; Proto-Oncogene Proteins B-raf; Sorafenib; Thyroid Gland

2015
Metabolic alterations and drug sensitivity of tyrosine kinase inhibitor resistant leukemia cells with a FLT3/ITD mutation.
    Cancer letters, 2016, 07-28, Volume: 377, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; fms-Like Tyrosine Kinase 3; G2 Phase Cell Cycle Checkpoints; Genetic Predisposition to Disease; Glycolysis; Humans; Leukemia, Myeloid, Acute; Mice; Mitochondria; Mutation; Niacinamide; Phenotype; Phenylurea Compounds; Protein Kinase Inhibitors; Pyruvates; Signal Transduction; Sorafenib; Tandem Repeat Sequences; Time Factors

2016
Sorafenib and 2-Deoxyglucose Synergistically Inhibit Proliferation of Both Sorafenib-Sensitive and -Resistant HCC Cells by Inhibiting ATP Production.
    Gene expression, 2017, 02-10, Volume: 17, Issue:2

    Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Deoxyglucose; Drug Synergism; G1 Phase; Humans; Liver Neoplasms; Niacinamide; Phenylurea Compounds; Resting Phase, Cell Cycle; Sorafenib

2017
ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition.
    Leukemia, 2017, Volume: 31, Issue:10

    Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Cell Line; Cell Transformation, Neoplastic; Deoxyglucose; fms-Like Tyrosine Kinase 3; Glycolysis; Hematopoietic Stem Cells; Hexokinase; Humans; Hydrocarbons, Brominated; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Microsatellite Repeats; Mitochondria; Molecular Targeted Therapy; Neoplasm Proteins; Niacinamide; Phenylurea Compounds; Propionates; Proto-Oncogene Proteins c-akt; Sorafenib

2017
Nicotinamide-N-methyltransferase is a promising metabolic drug target for primary and metastatic clear cell renal cell carcinoma.
    Clinical and translational medicine, 2022, Volume: 12, Issue:6

    Topics: Carcinoma, Renal Cell; Deoxyglucose; Glucose; Glutamine; Humans; Kidney Neoplasms; Niacinamide; Tumor Microenvironment

2022